Leslie V Norwalk
CIK 1533568 · View on SEC EDGAR ↗
First SEC filing: June 8, 2026 · Latest: June 8, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2026 | NBIX | S 10b5-1 | 1,250 | $182.01 | $227,512 | 1,588 Direct | -44.05% | Disposed | -15.4% (price as of 2026-08-21) |
| June 4, 2026 | NBIX | S | 1,250 | $168.06 | $210,072 | 2,838 | — | — | -8.3% (price as of 2026-08-21) |
| Jan. 8, 2026 | GMED | S 10b5-1 | 2,000 | $101.10 | $202,200 | 10,419 Direct | -16.10% | Disposed | -15.7% (price as of 2026-08-21) |
| Dec. 12, 2025 | GMED | S 10b5-1 | 4,000 | $88.85 | $355,400 | 12,419 Direct | -24.36% | Disposed | -4.0% (price as of 2026-08-21) |
| July 11, 2024 | GMED | S 10b5-1 | 1,000 | $70.00 | $70,000 | 16,419 Direct | -5.74% | Disposed | 21.8% (price as of 2026-08-21) |
| May 17, 2024 | NBIX | S 10b5-1 | 1,106 | $141.82 | $156,853 | 994 Direct | -52.67% | Disposed | 8.6% (price as of 2026-08-21) |
| March 15, 2024 | GMED | S 10b5-1 | 10,590 | $51.99 | $550,574 | 17,419 Direct | -37.81% | Disposed | 64.0% (price as of 2026-08-21) |
| Feb. 27, 2024 | NBIX | S 10b5-1 | 8,000 | $135.67 | $1,085,360 | 0 Direct | -100.00% | Disposed | 13.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 29, 2026 | NBIX | Non-Qualified Stock Option | Common Stock (842) | $139.43 | May 22, 2034 | 842 | Disposed |
| June 24, 2026 | ARVN | Stock Option (right to buy) | Common Stock (22,714) | $8.05 | June 23, 2036 | 22,714 | Acquired |
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $94.15 | Jan. 21, 2036 | 15,000 | Acquired |
| May 22, 2025 | NBIX | Restricted Stock Unit [F1] | Common Stock (1,435) | $0.00 | — | 1,435 | Disposed |
| May 21, 2025 | NBIX | Non-Qualified Stock Option | Common Stock (3,305) | $120.56 | May 21, 2035 | 3,305 | Acquired |
| May 21, 2025 | NBIX | Restricted Stock Unit [F1] | Common Stock (1,659) | $0.00 | — | 1,659 | Acquired |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $92.42 | Jan. 23, 2035 | 15,000 | Acquired |
| May 22, 2024 | NBIX | Non-Qualified Stock Option | Common Stock (2,982) | $139.43 | May 22, 2034 | 2,982 | Acquired |
| May 22, 2024 | NBIX | Restricted Stock Unit [F1] | Common Stock (1,435) | $0.00 | — | 1,435 | Acquired |
| May 17, 2024 | NBIX | Restricted Stock Unit | Common Stock (2,100) | — | — | 2,100 | Disposed |
| Feb. 27, 2024 | NBIX | Non-Qualified Stock Option | Common Stock (8,000) | $84.95 | May 18, 2032 | 8,000 | Disposed |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $53.75 | Jan. 26, 2034 | 15,000 | Acquired |
| Sept. 1, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $54.23 | Sept. 1, 2033 | 15,000 | Acquired |
| May 17, 2023 | NBIX | Restricted Stock Unit | Common Stock (2,100) | — | — | 2,100 | Acquired |
| May 17, 2023 | NBIX | Non-Qualified Stock Option | Common Stock (4,290) | $95.27 | May 17, 2033 | 4,290 | Acquired |
| June 16, 2022 | ARVN | Stock Option (right to buy) | Common Stock (10,192) | $36.79 | June 15, 2032 | 10,192 | Acquired |
| May 18, 2022 | NBIX | Non-Qualified Stock Option | Common Stock (9,724) | $84.95 | May 18, 2032 | 9,724 | Acquired |
| Feb. 7, 2022 | CNC | Common Stock Option (right to buy) | Common Stock (10,000) | $80.57 | Feb. 7, 2032 | 10,000 | Acquired |
| June 8, 2021 | ARVN | Stock Option (right to buy) | Common Stock (7,511) | $78.53 | June 7, 2021 | 7,511 | Acquired |
| May 19, 2021 | NBIX | Non-Qualified Stock Option | Common Stock (8,833) | $92.35 | May 19, 2031 | 8,833 | Acquired |
| June 3, 2020 | ARVN | Stock Option (right to buy) | Common Stock (12,000) | $33.57 | June 2, 2030 | 12,000 | Acquired |
| May 19, 2020 | NBIX | Non-Qualified Stock Option | Common Stock (6,018) | $119.93 | May 19, 2030 | 6,018 | Acquired |
| Sept. 10, 2019 | NBIX | Non-Qualified Stock Option | Common Stock (15,000) | $95.18 | Sept. 10, 2029 | 15,000 | Acquired |
| July 24, 2019 | ARVN | Stock Option (right to buy) | Common Stock (25,846) | $24.30 | July 23, 2029 | 25,846 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 18, 2022 | CNC | No Securities Beneficially Owned | 0 | Direct |